| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/22/2002 | WO2000011186A9 Modified hcv peptide vaccines |
| 08/22/2002 | WO2000006771A9 Nucleic acid labeling compounds |
| 08/22/2002 | WO1999065927A9 Method for producing polynucleotides with desired properties |
| 08/22/2002 | WO1999058143A9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 08/22/2002 | US20020116737 Inducing necrotic effect in preferential cells of plant; obtain plant, transform preferential cells with vector containing antiviral protein, monitor expression of antiviral protein in cells |
| 08/22/2002 | US20020116736 Modification of sucrose synthase gene expression in plant tissue and uses therefor |
| 08/22/2002 | US20020116735 Nucleotide sequences coding enzymatic protein for use in the biosyntheis of waxes in plants |
| 08/22/2002 | US20020116734 Plant derived bag homologues |
| 08/22/2002 | US20020116733 Generating disease resistant plant sesds; obtain seeds, incubate with hypersensitive response protein, classify plants propagated from seeds |
| 08/22/2002 | US20020116731 Expression vector coding polypeptide for use in the treatment of diabetes |
| 08/22/2002 | US20020116730 Expression vector coding enzymatic polypeptide for use in the treatment convulsions and spasms |
| 08/22/2002 | US20020116729 Expression vector coding enzymatic polypeptide for use in the treatment psychological disorders |
| 08/22/2002 | US20020116728 Transgenic mice containing Kir5.1 inwardly rectifying potassium channel gene disruptions |
| 08/22/2002 | US20020116727 Expression vector coding binding protein for use in the treatment of inflammatory and immunoregulatory defects |
| 08/22/2002 | US20020116726 Muir-torre-like syndrome in Fhit deficient mice |
| 08/22/2002 | US20020116725 Method to increase cerebral blood flow in amyloid angiopathy |
| 08/22/2002 | US20020116724 Nucleotide sequences codingolypeptide for use in the diagnosis and prevention of psoriasis and venous ulcers |
| 08/22/2002 | US20020116723 Insect expression vectors |
| 08/22/2002 | US20020115851 Ammonium sulfate for neutralization of inhibitory effects |
| 08/22/2002 | US20020115850 Expression vector for use in generation of disease resistant plants |
| 08/22/2002 | US20020115849 Plant promoter activated by fungal infection |
| 08/22/2002 | US20020115848 IBD-associated microbial nucleic acid molecules |
| 08/22/2002 | US20020115847 Nuclear receptor of given amino acid sequence; receptor modulates 9-cis retinoic acid signalling |
| 08/22/2002 | US20020115846 Nucleotide sequences coding protein for use in human therapeutics and diagnostics |
| 08/22/2002 | US20020115845 Promoter |
| 08/22/2002 | US20020115844 Novel human lipase and polynucleotides encoding the same |
| 08/22/2002 | US20020115843 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 08/22/2002 | US20020115842 Novel human proteases and polynucleotides encoding the same |
| 08/22/2002 | US20020115839 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of cell proliferative, differentiation and migration defects |
| 08/22/2002 | US20020115838 Nucleotide sequences coding enzymatic polypeptide for use in human therapeutics and diagnostics |
| 08/22/2002 | US20020115837 Nucleoide sequences coding protein for use in human therapeutics and diagnostics |
| 08/22/2002 | US20020115834 New process for the production of biologically active protein |
| 08/22/2002 | US20020115832 Methods for producing factor VIII proteins |
| 08/22/2002 | US20020115829 Pathogenic escherichia coli associated protein |
| 08/22/2002 | US20020115827 Stabilizaton of heat resistant protein; obtain protein, replace aspartic acids with glutamic acids, recover protein |
| 08/22/2002 | US20020115825 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier |
| 08/22/2002 | US20020115824 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 08/22/2002 | US20020115631 Human bad polypeptides, encoding nucleic acids and methods of use |
| 08/22/2002 | US20020115629 Aptamer-mediated regulation of gene expression |
| 08/22/2002 | US20020115627 Phosphatonin-related gene and methods of use thereof |
| 08/22/2002 | US20020115626 Comparing the expression of the nucleic acid encoding an antileuko-protease polypeptide of a cell population to the expression of a nucleic acid encoding the same peptide in an inflammation positive reference profile; enzyme inhibitors |
| 08/22/2002 | US20020115610 Isolated polypeptides that stimulate gastrointestinal smooth muscle contraction, including human; ionotropic agents; enhanced gastrointestinal motility; identifying a prokineticin receptor ligand; calcium mobilization |
| 08/22/2002 | US20020115608 Uses of transgenic animals containing a type X collagen mutant |
| 08/22/2002 | US20020115603 Methods and compositions for the treatment of peripheral artery disease |
| 08/22/2002 | US20020115602 Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide |
| 08/22/2002 | US20020115600 Inhibitors of memapsin 2 and use thereof |
| 08/22/2002 | US20020115599 Nucleic acid of given sequence; protein involved in mechanisms during mitosis |
| 08/22/2002 | US20020115595 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
| 08/22/2002 | US20020115220 Plasmid for use as tools in the transformation of candida cells |
| 08/22/2002 | US20020115219 Transforming cell with preferential nucleotide sequences; obtain cell, bore aperature in cell wall or mem brane, transform with nucleotide sequences recover transformed cells |
| 08/22/2002 | US20020115218 Gene delivery vectors with cell type specificity for primary human chondrocytes |
| 08/22/2002 | US20020115215 Adjusting chromatin in cells; obtain cells, incubate with fusion proteins, monitor activity of chromosomes |
| 08/22/2002 | US20020115210 Vectors and methods for the mutagenesis of mammalian genes |
| 08/22/2002 | US20020115209 Animal model for identifying agents that inhibit or enhance CTLA4 signaling |
| 08/22/2002 | US20020115207 Methods and compositions for use in spliceosome mediated RNA trans-splicing |
| 08/22/2002 | US20020115205 Receptor protein for use in the treatment of cancer, infections, psoraisis, asthma, allergies, viral diseases, arteriosclerosis, gland, eye, autoimmune, nervous system and psychological disorders |
| 08/22/2002 | US20020115203 Proteins for use in the treatment infectious, cancers and autoimmune disease |
| 08/22/2002 | US20020115202 Adenoviral vectors including dna sequences encoding angiogenic inhibitors |
| 08/22/2002 | US20020115195 Containers with two sections, separated by semipermeable material which a microbe passes but cells from (non)target cells cannot, and connected by conduits with circulation exits and entrances, a pump, and a way to mutate microbes |
| 08/22/2002 | US20020115189 Generating genetically engineered, adeno-associated virons: obtain cells, transform with viral vector, express vector, recover transformed cells, culture cells and recover virons |
| 08/22/2002 | US20020115188 Genetically engineered baculovirus for use as a tool in gene therapy |
| 08/22/2002 | US20020115187 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent |
| 08/22/2002 | US20020115186 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects |
| 08/22/2002 | US20020115184 Antibiotic protein and method of production |
| 08/22/2002 | US20020115183 Enzymatic protien for us ein prevention of tumor metastasis |
| 08/22/2002 | US20020115181 Enzymatic polypeptide for use in paper making and animal feeds |
| 08/22/2002 | US20020115180 Splicing factor |
| 08/22/2002 | US20020115179 Peptide for use in the treatment of asthma, arthritis and respiratory disorders |
| 08/22/2002 | US20020115178 16816 and 16839, novel human phospholipase C molecules and uses therefor |
| 08/22/2002 | US20020115177 Regulation of human histone deacetylase |
| 08/22/2002 | US20020115176 Polypeptide for use in the diagnosis and treatment of asthma, and respiratory disorders |
| 08/22/2002 | US20020115172 Polypeptides for use in the diagnosis, prevention, and treatment of inflammation, cell proliferation and apoptosis disorders |
| 08/22/2002 | US20020115171 Polypeptides for use in the diagnosis, prevention, and treatment of inflammation, cell proliferation and apoptosis disorders |
| 08/22/2002 | US20020115170 Polypeptides having peroxidase activity and nucleic acids encoding same |
| 08/22/2002 | US20020115167 Isolation of drosophila and human polynucleotides encoding PAR-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 08/22/2002 | US20020115166 Peptide for use in the treatment of pancreatic defects |
| 08/22/2002 | US20020115162 Nucleotide sequences coding for the cysQ gene |
| 08/22/2002 | US20020115159 Nucleotide sequences coding preferential protein for use human medicine, therapeutics, foods and animal nutrients |
| 08/22/2002 | US20020115157 Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof |
| 08/22/2002 | US20020115156 Connective tissue growth factor for use in the treatment of cancer, fibrotic defects and atherosclerosis; for use as wound healing agents |
| 08/22/2002 | US20020115154 Trail receptors, nucleic acids encoding the same, and methods of use thereof |
| 08/22/2002 | US20020115153 Polypeptide for use in the treatment, diagnosis and prevention of cell proliferation defects and inflammation |
| 08/22/2002 | US20020115152 Expression system for factor VIII |
| 08/22/2002 | US20020115151 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment |
| 08/22/2002 | US20020115150 Polypeptide for use in the treatment and diagnosis of vision defects and diabetes |
| 08/22/2002 | US20020115148 Nucleotide sequences coding polypeptide for use the treatment of skin disorders |
| 08/22/2002 | US20020115147 Method for producing an active heterodimeric AMV-RT in prokaryotic cells |
| 08/22/2002 | US20020115146 Method of protein synthesis |
| 08/22/2002 | US20020115145 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/22/2002 | US20020115144 Nucleotide sequences coding protein for use in the diagnosis and treatment of intracellular vessicle defects |
| 08/22/2002 | US20020115143 Expression vector coding immunoglobulin for use in the of infections and cancer |
| 08/22/2002 | US20020115140 Nucleotide sequences coding preferential polypeptide for use in treatment of immmunological defects |
| 08/22/2002 | US20020115138 Nucleotide sequences coding transport protein for use in treat ment of tumors |
| 08/22/2002 | US20020115136 Peptide for use in the treatment, diagnosis and prevention of pancreatic disorders and grave's diease |
| 08/22/2002 | US20020115135 Synapse related glycoproteins |
| 08/22/2002 | US20020115120 Controlling polypetide activity in cell; obtain cell, incubate with modulator, monitor gene expression and protein activity |
| 08/22/2002 | US20020115114 Detecting modulators of kinase activity; obtain enzymatic polypeptide, incubate with modulator, monitor binding activity of kinases |
| 08/22/2002 | US20020115110 Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
| 08/22/2002 | US20020115109 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 08/22/2002 | US20020115108 Enzymes having high temperature polymerase activity and methods of use thereof |